Compounds > ranolazine
Page last updated: 2024-08-24

ranolazine and Dyspnea

ranolazine has been researched along with Dyspnea in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damulevičienė, G; Galaunė, V; Gumbrevičius, G; Gumbrevičiūtė, M1
Arnold, SV; Cohen, DJ; Grantham, JA; Hirai, T; Jones, P; Karmpaliotis, D; Lombardi, W; Moses, J; Nicholson, WJ; Patterson, C; Qintar, M; Salisbury, AC; Sapontis, J; Sheehy, J; Spertus, JA; Tang, Y1
Gentry, JL; Hurdle, M; Mentz, RJ; Wang, A1
Arnold, SV; Braunwald, E; Cohen, DJ; Lei, Y; Mahoney, EM; Morrow, DA; Scirica, BM; Wang, K1
Bashore, TM; Goswami, R; Schmader, KE; Sketch, MH; Van De Car, D1
Freudenberger, R; Levin, V; Martinez, MW; Nanda, S1

Trials

1 trial(s) available for ranolazine and Dyspnea

ArticleYear
Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
    Circulation. Cardiovascular quality and outcomes, 2008, Volume: 1, Issue:2

    Topics: Acetanilides; Acute Coronary Syndrome; Aged; Angina, Unstable; Disease Progression; Double-Blind Method; Dyspnea; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Quality of Life; Ranolazine; Surveys and Questionnaires

2008

Other Studies

5 other study(ies) available for ranolazine and Dyspnea

ArticleYear
Possible Interaction between Dabigatran and Ranolazine in Patients with Renal Failure.
    Medicina (Kaunas, Lithuania), 2019, Dec-29, Volume: 56, Issue:1

    Topics: Aged; Blood Coagulation; Cough; Dabigatran; Drug Interactions; Dyspnea; Factor Xa Inhibitors; Fatigue; Fever; Humans; Male; Ranolazine; Renal Insufficiency

2019
De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status.
    American heart journal, 2019, Volume: 214

    Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Coronary Occlusion; Dyspnea; Female; Health Status; Health Surveys; Humans; Logistic Models; Male; Myocardial Ischemia; Nitro Compounds; Percutaneous Coronary Intervention; Prospective Studies; Quality of Life; Ranolazine; Registries; Time Factors

2019
Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME).
    Journal of the American College of Cardiology, 2016, 10-18, Volume: 68, Issue:16

    Topics: Aged; Angina Pectoris; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Dyspnea; Female; Humans; Male; Middle Aged; Pilot Projects; Ranolazine

2016
Ranolazine-related dyspnea on exertion.
    The American journal of geriatric pharmacotherapy, 2010, Volume: 8, Issue:1

    Topics: Acetanilides; Aged; Dyspnea; Enzyme Inhibitors; Exercise Test; Humans; Male; Physical Exertion; Piperazines; Ranolazine

2010
Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
    Pacing and clinical electrophysiology : PACE, 2010, Volume: 33, Issue:12

    Topics: Acetanilides; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Coronary Artery Bypass; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dyspnea; Enzyme Inhibitors; Humans; Male; Middle Aged; Piperazines; Ranolazine; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes

2010